Clinical Trials Directory

Trials / Completed

CompletedNCT06098066

Decoding Risks and Rewards in Ischemic Stroke Surgery

Decoding the Surgical Enigma: A Groundbreaking Nationwide Study Unveils the Risks and Rewards of EC-IC Bypass, CEA, and CAS in Ischemic Cerebrovascular Disease

Status
Completed
Phase
Study type
Observational
Enrollment
204,411 (actual)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

In the high-stakes battle against ischemic cerebrovascular disease, where every second counts and the margin for error is slim, how do the investigators tip the scales in favor of patient survival and improved outcomes? This groundbreaking study, the first nationwide, population-based analysis with long-term follow-up in an Asian context, dives deep into this critical question. Leveraging an expansive dataset from Taiwan's National Health Insurance Research Database, the investigators scrutinize the efficacy and risks of aggressive surgical interventions-specifically, EC-IC bypass, CEA, and CAS-in a cohort of over 84,000 patients. This paper serves as a milestone, bridging the gap between medical idealism and clinical reality. It calls for a surgical renaissance, emphasizing the need for refining techniques and enhancing patient selection protocols. If participants're looking for a comprehensive, nuanced, and, above all, actionable insight into the surgical treatment of ischemic cerebrovascular disease, this is the study that could redefine the paradigm.

Conditions

Timeline

Start date
2020-05-01
Primary completion
2020-05-30
Completion
2023-01-31
First posted
2023-10-24
Last updated
2023-10-24

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06098066. Inclusion in this directory is not an endorsement.